Teva Pharmaceutical reported $20.31B in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Aspen Pharmacare APN:SJ ZAR 1.78B 187.82B
Guangzhou Baiy 600332:CH CNY 1.63B 0
Jiangsu Hengrui Me. 600276:CH CNY 6.38B 0
Kalbe Farma Tbk Pt KLBF:IJ IDR 468.75B 0
Richter Gedeon RICHT:HB HUF 18.64B 0
Sh Fosun Pharma 600196:CH CNY 2.67B 106.76M
Teva Pharmaceutical TEVA:IT USD 20.31B 387.03M